User profiles for M.-J. Milloy

MJ S Milloy, PhD

Assistant professor, Medicine, UBC; Research scientist, BCCSU
Verified email at ubc.ca
Cited by 4066

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study

BDL Marshall, MJ Milloy, E Wood, JSG Montaner… - The Lancet, 2011 - thelancet.com
Background Overdose from illicit drugs is a leading cause of premature mortality in North
America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users …

[HTML][HTML] Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

…, YF Yen, T Azim, SH Mehta, MJ Milloy… - The Lancet Infectious …, 2018 - thelancet.com
Background People who inject drugs (PWID) experience a high prevalence of incarceration
and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after …

Modelling the combined impact of interventions in averting deaths during a synthetic‐opioid overdose epidemic

…, R Balshaw, M Otterstatter, L Macdougall, MJ Milloy… - …, 2019 - Wiley Online Library
Background and aims The province of British Columbia (BC) Canada has experienced a
rapid increase in illicit drug overdoses and deaths during the last 4 years, with a provincial …

Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs

A Caudarella, H Dong, MJ Milloy, T Kerr… - Drug and alcohol …, 2016 - Elsevier
Objectives To examine the relationship between non-fatal overdose and risk of subsequent
fatal overdose. Methods We assessed risk factors for overdose death among two prospective …

Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users

MJ Milloy, T Kerr, J Buxton, T Rhodes… - Journal of infectious …, 2011 - academic.oup.com
(See the editorial commentary by Flanigan and Beckwith, on pages 1201–3 .) Background.
Although some studies have identified impressive clinical gains for incarcerated HIV-…

Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users

S Uhlmann, MJ Milloy, T Kerr, R Zhang, S Guillemi… - …, 2010 - Wiley Online Library
Aims Despite proven benefits of antiretroviral therapy (ART), many human immunodeficiency
virus (HIV)‐infected injection drug users (IDU) do not access treatment even in settings with …

Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users

SA Kinner, MJ Milloy, E Wood, J Qi, R Zhang, T Kerr - Addictive behaviors, 2012 - Elsevier
… MJ Milloy is supported by a doctoral research award from the Canadian Institutes of Health
Research. Funding sources had no involvement in study design; collection, analysis and …

Housing status and the health of people living with HIV/AIDS

MJ Milloy, BDL Marshall, J Montaner, E Wood - Current HIV/AIDS Reports, 2012 - Springer
Individuals who are homeless or living in marginal conditions have an elevated burden of
infection with HIV. Existing research suggests the HIV/AIDS pandemic in resource-rich settings …

[HTML][HTML] Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users

A Palepu, MJ Milloy, T Kerr, R Zhang, E Wood - Journal of Urban Health, 2011 - Springer
Homelessness is prevalent among HIV-infected injection drug users (IDU) and may adversely
affect access and adherence to antiretroviral therapy (ART). There are limited descriptions …

Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis

…, L Brinkley-Rubinstein, JJ Amon, MJ Milloy… - The Lancet, 2016 - thelancet.com
The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings
than in the non-incarcerated communities that surround them. In this comprehensive review…